Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Christopher Bichakjian MD

Christopher Bichakjian MD

Associate Professor of Dermatology, University of Michigan Medical School; Associate Chief, Division of Cutaneous Surgery and Oncology, University of Michigan Health System, Ann Arbor, Michigan

Dr. Christopher Bichakjian is an associate professor of Dermatology and Associate Chief of the Division of Cutaneous Surgery and Oncology at the University of Michigan Health System. He received his medical degree from Radboud University in The Netherlands and served his internship at Henry Ford Hospital in Detroit. He completed his dermatology residency with additional specialty residency training in melanoma at the University of Michigan in 2001. He completed additional advanced fellowship training in melanoma and cutaneous surgery (Mohs surgery) and oncology at the U-M Comprehensive Cancer Center. Following his departure from the University of Michigan to private practice in New York City, Dr. Bichakjian was recruited back to the U-M melanoma and cutaneous surgery and oncology faculty in 2004. Dr. Bichakjian has a special interest in Merkel cell carcinoma and serves as the director of the Comprehensive Cancer Center Multidisciplinary Merkel Cell Carcinoma program. Dr. Bichakjian is a member of the National Comprehensive Cancer Network (NCCN) Melanoma Guideline Panel and serves as chair of the NCCN Non-Melanoma Skin Cancer Panel.